Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 Mar 21, 2024
Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections Jan 30, 2024
